Neutropenia risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]
Overview
Overview
At-risk populations include those undergoing cytotoxic chemotherapy or other myelosuppressive medications, however a benign form of mild neutropenia is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia.
Risk Factors
Risk Factors
- Medications[1]
- Cytotoxic chemotherapy
- Hematologic malignancies
- Autoimmune disorders
- Infections
- Hemodialysis
- Radiation therapy
- Vitamin deficiencies e.g. folate, Vitamin B12
- Black, Yemenite, West Indian, or Arab Jordanian ethnicity
References
References
- ↑ Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). “Idiosyncratic drug-induced agranulocytosis: Update of an old disorder”. Eur J Intern Med. 17 (8): 529–35. Text “pmid 17142169” ignored (help)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH